New PLA facility in Thailand
NatureWorks has passed the final authorization milestone by parent companies Cargill and GC International Corporation, a subsidiary of PTT Group, for a new Ingeo PLA manufacturing facility in Thailand.
Corporate action on climate change is partly driven by a desire to get ahead of upcoming legislation. Reputation is also a major factor: it never hurts to be seen as a leader. But the bottom line is that markets will reward — and eventually demand — climate-friendly products and services, so it is important to understand how each solution can help to reduce or even avoid carbon emissions completely. The bioeconomy, byrenewable raw materials instead of fossil resources, helps mitigate climate change by reducing emissions from fossil carbon in the atmosphere and capturing more carbon in the biosphere.
Today, innovative and agile start-ups such as AFYREN, Genomatica, Novamont and Chaincraft B.V. are the driving force behind the introduction of new biotech solutions. Some are developing new technologies to produce chemicals in a more sustainable way. They either use alternative raw materials made from renewable biomass and agricultural by-products or they achieve significant reductions in energy consumption while operating existing production processes. Biobased “green chemistry” uses new methods to offer the same molecules as the conventional fossil-based processes with a significantly lower carbon footprint.
AFYREN offers a wide range of drop-in replacement molecules that are 100% biobased, created in a fully circular production process, and based on a local sourcing approach. AFYREN NEOXY is the first production facility to implement AFYREN’s Technology and know-how. Located at the CHEMESIS industrial platform in Carling Saint-Avold, it produces a family of 7 organic acids. The unique, environmentally friendly technology transforms agricultural byproducts into valuable chemical building blocks, such as acetic, propioninc and butyric acid. With this holistic strategy, AFYREN is able to offer companies from all industries low carbon solutions to help them reach or even exceed their ambitious carbon emission targets.
Chaincraft is building on nature’s principles and has developed a platform technology to produce sustainable and circular fatty acids for the agrifood and chemical & materials industries. In our unique biotechnological process different types of organic residues are robustly converted into a number of short and medium chain fatty acids, such as butyric, valeric and caprylic acid.
The so-called ‘chain elongation technology’ is ChainCraft’s first commercial scale proven technology. Building upon the wide variety of possibilities which open mixed culture fermentation bring, we are developing other innovative processes and products to be able to contribute to a circular and sustainable chemical industry.
Genomatica, a leader in enabling clean manufacturing, announced it has licensed its GENO BDO® biomanufacturing process technology to Cargill, which is using it in its newly-announced joint venture with HELM, Qore, to produce renewable 1,4-butanediol (BDO). The technology for the BDO production facility will be a part of the recently announced $300M investment by Cargill and HELM at the biotechnology campus in Eddyville, Iowa. With the completion of this facility in 2024, Genomatica’s technology will enable a combined, global production capacity of over 100,000 tons per year of renewable BDO. Companies around the world are rapidly rethinking their supply chains to meet increasing consumer and investor demand for responsible, transparent and sustainable sourcing of performance materials.
Since 2014, Bio-based Industries Joint Undertaking (BBI JU) has funded 11 flagship biorefineries in Europe, leveraging €1.3 billion in private investments to support the design and construction of the biorefineries, creating 3,500 new direct jobs and 10,000 indirect ones. Projects that have received funding include FARMŸNG, Exilva Cellulose Fibrils, First2Run, AgriChemWhey, PEFerence, AFTER-BIOCHEM, SWEETWOODS, Plenitude, Resolute, abacus, and Lignoflag.
Biobased economy or bioeconomy refers to economic activity involving the use of biotechnology in the production of (bio-based) goods, services, or energy from biological material (or biomass) as the primary resource base. An important aspect of the bioeconomy is understanding mechanisms and processes at the genetic, molecular, and genomic levels, and applying this understanding to creating or improving industrial processes, developing new products and services, and producing new energy.